Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 10, 2017 19:20 ET | Source: Fluidigm Corporation

Fluidigm Announces Sale of $30 Million of Common Stock in At-The-Market Equity Offering

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the sale of 9,090,909 shares of its common stock for aggregate gross proceeds of...
August 03, 2017 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Second Quarter Financial Results and Operational Progress

SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the second quarter ended June 30, 2017. Total revenue for the...
August 02, 2017 22:51 ET | Source: Fluidigm Corporation

Fluidigm 和 Ascendas Genomics 宣布建立战略合作关系在中国开发微流控分子诊断

加州南旧金山与中国中山市, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation（NASDAQ:FLDM）与 Ascendas Genomics 今日宣布建立战略合作，在中国开发分子诊断技术。根据合作条款，Ascendas Genomics 将使用 Fluidigm® Biomark™ HD 和 Juno™...
August 02, 2017 06:00 ET | Source: Fluidigm Corporation

Fluidigm Corporation Announces Termination of Tax Benefit Preservation Plan

SOUTH SAN FRANCISCO, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) announced today that its tax benefit preservation plan had expired pursuant to its terms,...
July 27, 2017 16:05 ET | Source: Fluidigm Corporation

Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China

SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop...
July 20, 2017 16:05 ET | Source: Fluidigm Corporation

Fluidigm to Report Q2 2017 Financial Results and Host Conference Call

SOUTH SAN FRANCISCO, Calif., July 20, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report second quarter 2017 financial results on Thursday, August 3,...
July 18, 2017 09:00 ET | Source: Fluidigm Corporation

Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research

SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR...
May 04, 2017 16:10 ET | Source: Fluidigm Corporation

European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research

SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement...
May 04, 2017 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces First Quarter Financial Results

SOUTH SAN FRANCISCO, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2017. Total revenue...
April 20, 2017 16:05 ET | Source: Fluidigm Corporation

Fluidigm to Report Q1 2017 Financial Results and Host Conference Call

SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced it will report first quarter 2017 financial results on Thursday, May 4, 2017, after...